Journal of Leukemia
Open Access

Daniel Re

Publications

• Review Article
  Chronic Lymphocytic Leukemia: Raising Expectations in the Treatment of Elderly Patients
  Author(s): Wolfgang Knauf and Daniel ReWolfgang Knauf and Daniel Re
  
  Many advances have been seen in CLL treatment in recent years, primarily benefitting young, fit patients. However, CLL is primarily a disease of the elderly, and many elderly patients currently receive sub-optimal treatment. This is in part due to a lack of consensus surrounding how best to classify their health status. In order to ensure that elderly patients, whether ‘fit’ or ‘unfit’ receive the most appropriate treatment, there is a need for refinement of the screening tools currently used, and furthermore, a need for standardization. Treatment regimens such as FCR, currently considered the standard of care for CLL treatment, often cannot be recommended for elderly patients who are frequently ineligible for fludarabine-based therapy due to co-morbidities. Several targeted ‘chemotherapy-free’ treatments are being investigated for use in these pati.. View More»
  DOI: 10.4172/2329-6917.1000181

  Abstract PDF

Relevant Topics